Get started
Author

Davide Racaniello

Observed institution: University of Bari Aldo Moro
OpenAlex ID: A5013533112
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
2022 · Sara Volpe, Giuseppe Lisco, et al. · Nutrients · 83
PDF
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
2023 · Sara Volpe, Giuseppe Lisco, et al. · Frontiers in Endocrinology · 71
PDF
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study
2022 · Sara Volpe, Giuseppe Lisco, et al. · Nutrients · 66
PDF
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
2024 · Sara Volpe, Alfredo Vozza, et al. · Nutrients · 20
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study
2025 · Alfredo Vozza, Domenico Triggiani, et al. · Frontiers in Endocrinology · 11
PDF
Works count: 5
Citation count: 251
H-index: 5
I10-index: 5
Year
Topic
Type